Why is the SARS-CoV-2 Omicron variant milder?
文献类型：期刊论文
| 作者 | Xia, Bingqing1,2; Wang, Yi1,3; Pan, Xiaoyan4; Cheng, Xi1,2; Ji, Hongying1; Zuo, Xiaoli1; Jiang, Hualiang1,2,5 ; Li, Jia1,2; Gao, Zhaobing1,2
|
| 刊名 | Innovation (Cambridge (Mass.))
 |
| 出版日期 | 2022-05-12 |
| 卷号 | 3期号:4页码:100251 |
| ISSN号 | 2666-6758 |
| DOI | 10.1016/j.xinn.2022.100251 |
| 文献子类 | News |
| 语种 | 英语 |
| WOS记录号 | MEDLINE:35497020 |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/309289]  |
| 专题 | 新药研究国家重点实验室 |
| 作者单位 | 1.CAS Key Laboratory of Receptor Research, Stake Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China; 2.University of Chinese Academy of Sciences, 19A Yuquan Road, Beijing 100049, China; 3.State Key Laboratory of Medical Neurobiology, Institutes of Brain Science, Fudan University, Shanghai 200032, China; 4.State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China; 5.Lingang Laboratory, Shanghai 201602, China |
| 推荐引用方式 GB/T 7714 | Xia, Bingqing,Wang, Yi,Pan, Xiaoyan,et al. Why is the SARS-CoV-2 Omicron variant milder?[J]. Innovation (Cambridge (Mass.)),2022,3(4):100251. |
| APA | Xia, Bingqing.,Wang, Yi.,Pan, Xiaoyan.,Cheng, Xi.,Ji, Hongying.,...&Gao, Zhaobing.(2022).Why is the SARS-CoV-2 Omicron variant milder?.Innovation (Cambridge (Mass.)),3(4),100251. |
| MLA | Xia, Bingqing,et al."Why is the SARS-CoV-2 Omicron variant milder?".Innovation (Cambridge (Mass.)) 3.4(2022):100251. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。